Unternehmensprofil · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · Shanghai
Land / Region
China
Börsengang
23. April 2004
Mitarbeiter
2.544
Buffett Score
72/100
Stark
Marktkapitalisierung9,71 Mrd. CN¥
Umsatz (TTM)3,93 Mrd. CN¥
EBITDA710,27 Mio. CN¥
Nettomarge15,29 %
ROE14,16 %
KGV (TTM)16,2
Erwartetes KGV23,42
EPS1,39 CN¥
Dividendenrendite3,15 %
52-Wochen-Spanne21,22 CN¥ – 30,18 CN¥

Daten von EODHD, dargestellt in der Berichtswährung; nur zu Informationszwecken, keine Anlageberatung.

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Geschichte

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Branchenposition

DemnächstDieser Abschnitt wird gerade ergänzt — schauen Sie bald wieder vorbei.

Noch keine Analysen zu dieser Aktie in Ihrer Sprache.